Minireviews
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Otorhinolaryngol. Aug 28, 2014; 4(3): 12-16
Published online Aug 28, 2014. doi: 10.5319/wjo.v4.i3.12
Prenatal diagnosis and management of nasal glioma
Richard Fox, Saleh Okhovat, Issa Beegun
Richard Fox, Saleh Okhovat, Issa Beegun, Department of Otolaryngology, West Middlesex University Hospital, Isleworth, Middlesex TW7 6AF, United Kingdom
Author contributions: Fox R performed the literature search; Fox R and Okhovat S screened the cases; Fox R, Okhovat S and Beegun I reviewed the articles and wrote this paper.
Correspondence to: Dr. Richard Fox, Department of Otolaryngology, West Middlesex University Hospital, Twickenham Rd, Isleworth, Middlesex TW7 6AF, United Kingdom. richardfox@doctors.org.uk
Telephone: +44-20-85602121
Received: January 18, 2014
Revised: June 10, 2014
Accepted: July 12, 2014
Published online: August 28, 2014
Processing time: 222 Days and 8.3 Hours
Abstract

Advances in foetal imaging have increased our detection rate of craniofacial abnormalities in utero. Nasal glioma is a rare, benign, congenital facial defect. Once detected, further imaging is required to assess for intracranial communication, the presence of additional defects, determine the patency of the aerodigestive tract and decide on timing of delivery. The authors review the current literature on diagnosis and management of nasal glioma in this rapidly advancing field of craniofacial anomalies detected in utero. Literature search of EMBASE and MEDLINE databases yielded 594 articles, which were screened by 2 independent reviewers. A total of 7 papers were selected after exclusion. There have been seven cases of prenatally diagnosed nasal glioma. The earliest of these was detected at 20 wk gestation. The majority were investigated with foetal magnetic resonance imaging (MRI) to establish any intracranial communication or bony defects. Ultrasound monitoring, doppler waveform and 3D rendered images were utilised to delineate the lesion, monitor growth and differentiate potential diagnosis. Postnatal MRI is favoured by most to re-evaluate the lesion and aid surgical planning. Surgical resection was performed within the first few months of life. Diagnostic uncertainty was seen in all cases, until formal histology was obtained, emphasising the challenges, and need for early appropriate specialist input. Whilst the prenatal detection of craniofacial abnormalities increases, there remain diagnostic challenges in differentiating prenatal congenital midfacial defects in utero. These defects are best investigated and monitored using prenatal ultrasound and MRI, to narrow the differential diagnosis, guide timing of delivery and allow for appropriate surgical planning. Prenatally detected nasal glioma, may only be confirmed on histology and families must be counselled appropriately to prepare them for the possible alternative diagnoses. Early surgical resection was undertaken to achieve more favourable aesthetic outcomes, reduce complications of ocular development and provide definitive histological diagnosis.

Keywords: Nasal glioma; Prenatal; Craniofacial; Imaging

Core tip: Advances in foetal imaging have increased our detection rate of craniofacial abnormalities in utero. This enables early surgical input providing differential diagnosis, surgical planning, timing of delivery and counselling for families. Seven cases of prenatally diagnosed nasal glioma have been reported. The authors advocate ultrasound and foetal magnetic resonance imaging (MRI) to delineate the lesion, exclude intracranial involvement and monitor size. Foetal MRI also provides accurate delineation of the upper aerodigestive tract, allowing clinicians to anticipate airway compromise, in this otherwise benign condition. Early surgical resection is advised, for better aesthetic outcomes and to ensure normal ocular development.